Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
2.360
-0.140 (-5.60%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $56.18 million as of October 9, 2026. It is the 29,604th most valuable company in the world and the 4,579th biggest in the United States. Its market cap has decreased by 54.42% in one year.
Market Cap
56.18M
Enterprise Value
-35.96M
1-Year Change
-54.42%
Global Rank
Country Rank
#4,579 United States
Category
ChartMarket Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $56.18M, a decrease of -73.81%. That is a compound annual growth rate of -57.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 56.18M | -64.41% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gossamer Bio | 62.21M |
| RenovoRx | 61.83M |
| Pliant Therapeutics | 61.30M |
| Alterity Therapeutics | 60.60M |
| Eloxx Pharmaceuticals | 60.06M |
| Boundless Bio | 60.05M |
| Fractyl Health | 59.96M |
| Connect Biopharma Holdings | 59.49M |